SCHEMBL3479004

SCHEMBL3479004

CN(C)/C=N/C(=O)c1cncnc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.42
POLB P06746 3/20 0.38
HTT P42858 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
ALDH1A1 P00352 7/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
GAA P10253 1/20 0.36
KDM4E B2RXH2 2/20 0.34
RECQL P46063 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479005 1.00 HCAR2 (0.42) HCAR2POLBHTTL3MBTL1ALDH1A1
SCHEMBL30503716 0.80 HCAR2 (0.37) HCAR2ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL11259705 0.80 ALDH1A1 (0.49) HCAR2HTTALDH1A1MEN1KMT2A
SCHEMBL11259703 0.80 ALDH1A1 (0.49) HCAR2HTTALDH1A1MEN1KMT2A
SCHEMBL1919347 0.78 HTT (0.51) POLBHTTL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL1919344 0.78 HTT (0.51) POLBHTTL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL3272288 0.78 HTT (0.51) POLBHTTL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL13887207 0.75 HTT (0.49) POLBHTTALDH1A1SMN1; SMN2MEN1
SCHEMBL21408786 0.74 HCAR2 (0.47) HCAR2POLBHTTL3MBTL1ALDH1A1
SCHEMBL21431824 0.74 HCAR2 (0.47) HCAR2POLBHTTL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104877001-B Antifungal formulations 西尼克斯公司 2020-07-03 CN disclosed
EP-2326172-B1 ANTIFUNGAL AGENTS SCYNEXIS INC (US) 2014-10-22 EP disclosed
EP-2326172-B1 ANTIFUNGAL AGENTS SCYNEXIS INC (US) 2014-10-22 EP disclosed
US-8188085-B2 Antifungal agents MERCK SHARP & DOHME CORP. (US) 2012-05-29 US disclosed
US-8188085-B2 Antifungal agents MERCK SHARP & DOHME CORP. (US) 2012-05-29 US disclosed
US-8188085-B2 Antifungal agents MERCK SHARP & DOHME CORP. (US) 2012-05-29 US disclosed
US-20100113439-A1 Antifungal agents MERCK & CO., INC. (US) 2010-05-06 US disclosed
US-20100113439-A1 Antifungal agents MERCK & CO., INC. (US) 2010-05-06 US disclosed
US-20100113439-A1 Antifungal agents MERCK & CO., INC. (US) 2010-05-06 US disclosed
WO-2010019203-A1 ANTIFUNGAL AGENTS MERCK SHARP & DOHME CORP. (US) 2010-02-18 WO disclosed
WO-2010019204-A1 ANTIFUNGAL AGENTS MERCK SHARP & DOHME CORP. (US) 2010-02-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113439-A1 Antifungal agents GMDS, GBA3, UGGT1 HCAR2 3363/4885POLB 2806/4885HTT 4211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.